Medtech firm Biofourmis doubles valuation with acquisition, Novartis deal

Boston ’s Biofourmis Inc. is acquiring longtime partner Biovotion, leveraging its software and data-collection capabilities in a new multi-year partnership with Novartis.

Source: bizjournals.com Health Care:Biotechnology headlines - November 18, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news